Supporters
| Product Theater Schedule | | Print | |
|
Product Theaters offer an in-depth look at new senior care programs, medications, and other concepts changing the way consultant pharmacists do business today.
Continuing education credit is not provided for these programs as they are promotional in nature. The American Society of Consultant Pharmacists does not represent or endorse the content and products discussed during product theater programs. The presenting companies provide all descriptions and presentations. At some product theaters, meals may be provided by the presenting companies as a courtesy for professionals attending the programs.
Product Theater topics, descriptions, and speakers are added regularly. Check back often for updates.
Wednesday, November 166:30 a.m. - 7:30 a.m. Speakers: Pseudobulbar affect (PBA) is characterized by involuntary, sudden, and frequent episodes of crying and/or laughing. PBA occurs in approximately 10% to 20% of patients with certain neurologic conditions, including amyotrophic lateral sclerosis (ALS), dementia, multiple sclerosis (MS), Parkinson’s disease, stroke, and traumatic brain injury. Please attend this presentation to hear and discuss the definition and characteristics of PBA, watch impactful patient videos, and learn about therapeutic options and recent advancements in the treatment of PBA. Presented by Avanir Pharmaceuticals
6:30 a.m. - 7:30 a.m. This program is sponsored by and the speaker is presenting on behalf of Lilly USA, LLC. It is being presented consistent with FDA guidelines and is not approved for continuing education credit.
Speaker:
As of January 1, 2011, if you are a US medical doctor or doctor of osteopathy with an active state license number, the value of the meal that you receive when attending this program may be disclosed on Eli Lilly and Company's Physician Payment Registry as a transfer of value made to you by Lilly. As a result of enacted state regulations, food, beverage, and/or meals will not be provided for healthcare professionals from the states of Minnesota, Massachusetts, and Vermont. This medical presentation is intended only for invited healthcare professionals for whom the information to be presented is relevant to their practice. We regret that spouses or other guests cannot be accommodated.
Humalog® (100 units/mL) is a registered trademark of Eli Lilly and Company and is available by prescription only.
Presented by Lilly USA, LLC
7:45 a.m. - 8:45 a.m. Speaker: St. Louis College of Pharmacy Presented by AstraZeneca
7:45 a.m. - 8:45 a.m. Speaker: NuScriptRX A comprehensive overview of a long-term care pharmacy's implementation and adoption of short cycle pouch packaging by an industry leader, Ed Mercandante of NuScriptRX. This session will review how the decision was made to transition to pouch packaging, the choice of multi-dose and unit dose format, length of cycle fill and the operational impact to the pharmacy. Ed will also discuss how the pharmacy achieved the goals of reduced packaging and labor costs while providing waste reduction and increased medication access at the facility. Additional topics include a hybrid dispensing model using medication cabinets, eMAR and barcoding with pouch packaging. This session will focus on practical tools and methods for converting to a short cycle dispense method.
Presented by TCGRx
Thursday, November 176:30 a.m. - 7:30 a.m. Presented by Boehringer Ingelheim
6:30 a.m. - 7:30 a.m.
Speaker: Todd Berner, MD Health Outcomes and Pharmacoeconomics Research & Development Endo Pharmaceuticals Pain Management is a critical component within long-term care settings. This program will discuss the most up-to-date quality indicators for pain management including assessment of pain in the elderly and recognizing pain in the cognitively impaired. It includes the impact of polypharmacy on quality and outcomes measures.
Presented by Endo Pharmaceuticals
6:30 a.m. - 7:30 a.m. Speaker: Randolph V. Fugit, PharmD, BCPS This program is about the treatment of chronic idiopathic constipation in adults. We will also discuss the treatment of irritable bowel syndrome with constipation (IBS-C) in women 18 years of age and older. Presented by Takeda Pharmaceuticals
7:45 a.m. - 8:45 a.m.
Speaker: Manuel A. Suarez-Barcelo, MD, CMD Mount Sinai Medical Center Presented by Amgen
7:45 a.m. - 8:45 a.m. Speaker: Brian R. Tulloch, MD Clinical Associate Professor University of Texas Medical School Clinical Endocrinologist Diagnostic Clinic of Houston
Novo Nordisk and the National Diabetes Education Initiative® (NDEI®) have partnered with national experts in diabetes to present a compelling educational program focusing on the role of insulin analog therapy for management of diabetes among older adults in the long-term care (LTC) setting. Part 1 of this program will review current management standards for diabetes and provide strategies for overcoming barriers to optimal treatment. In Part 2, the clinical benefits of insulin analog therapy will be discussed. This is a promotional medical education presentation; it will not be certified for continuing education credit. This program is sponsored by Novo Nordisk.
Objectives:
Presented by Novo Nordisk
7:45 a.m. - 8:45 a.m. Speaker:
You are invited to attend a lecture reviewing clinical data on DALIRESP® (roflumilast). This program is designed to educate healthcare professionals about DALIRESP and reducing the risk of COPD exacerbations in patients with severe COPD associated with chronic bronchitis and a history of exacerbations. Presented by Forest Pharmaceuticals
11:45 a.m. - 12:45 p.m. Speaker: NewCourtland LIFE The speaker will discuss the evaluation of Alzheimer’s Disease throughout its course as well as the considerations to help manage the disease. This is a promotional event brought to you by Eisai Inc. and Pfizer Inc. CE/CME credit will not be available for this session. In compliance with PhRMA guidelines, spouses and other guests of health care professionals are not permitted to attend company‐sponsored programs. Certain restrictions apply. Presented by Eisai Inc. and Pfizer Inc.
11:45 a.m. - 12:45 p.m. The First Buprenorphine Transdermal System
Speaker: William Simonson, PharmD, CGP, FASCP
Join your colleagues for this informative product theater and gain valuable insight about the first buprenorphine transdermal system. Full Prescribing Information, including Boxed Warning, will be distributed and discussed at the presentation. Presented by Purdue Pharma
1:00 p.m. - 2:00 p.m. The Safety and Efficacy of XARELTO in the Long-Term Care Setting
Presented by Johnson & Johnson Health Care Companies
1:00 p.m. - 2:00 p.m. Approaches for Reducing Hyperuricemia in Patients with Gout Speaker: Gout is caused by hyperuricemia. It is the most common inflammatory arthritis, affecting as many as 6 million individuals in the US. Join us for a lively discussion about how to help manage hyperuricemia in patients with this chronic, progressive disease. Presented by Takeda Pharmaceuticals
5:15 p.m. - 7:15 p.m. Speakers: Don’t miss this opportunity to engage in discussion with a leading physician and consultant pharmacist in long-term care presenting poster displays that review cognitive assessment requirements included in the federally mandated MDS 3.0, and the management of moderate to severe Alzheimer’s disease. There will be two opportunities at 5:15 p.m. and 6:15 p.m. to attend this unique educational experience designed to encourage dialogue and small group interactions among peers. Presented by Forest Pharmaceuticals
Friday, November 186:30 a.m. - 7:30 a.m. Speaker: James R. Gavin III, MD, PhD CEO & Chief Medical Officer Healing Our Village, Inc. Clinical Professor of Medicine Emory University School of Medicine This product theater will review the clinical and economic impact of type 2 diabetes mellitus in adults, highlight results of clinical studies of TRADJENTA, and discuss the implications of this information for consultant pharmacists. Presented by Boehringer Ingelheim
7:45 a.m. - 8:45 a.m. Speaker: Hyperparathyroidism is a common, early complication of Chronic Kidney Disease. This program will take an in-depth look at Secondary Hyperparathyroidism. Presented by Abbott Laboratories
7:45 a.m. - 8:45 a.m. New Options for Influenza Prevention: An Influenza Vaccine for Older Adults
Speaker: Frank Breve, PharmD, MBA, CGP
Every year, influenza strikes millions of Americans of all ages. People 65 years of age and older are most severely affected. They account for more than 60% of influenza-related hospitalizations and 90% of deaths. Unfortunately, traditional influenza vaccines can be less effective in elderly persons than in younger adults. This session will review the key clinical data for an influenza vaccine developed specifically for persons 65 years of age and older.
Presented by Sanofi Pasteur
12:30 p.m. - 1:30 p.m. Optimizing the Management of COPD in Long-Term Care: Twice-Daily Nebulization Can Make a Difference in Certain Residents
Speakers: Dana Saffel, PharmD President, CEO PharmaCare Strategies, Inc.
Thomas C. Snader, PharmD, CGP, FASCP Independent Consultant Pharmacist Deans Professor of Clinical Pharmacy University of the Sciences in Philadelphia
This program will allow participants to:
Presented by Dey Pharma, L.P.
12:30 p.m. - 1:30 p.m. Post-Consumption Billing and the Impacts of Prior Authorization
Speaker: Sam Rajan, RPh Co-founder and Principal CoverMyMeds
A prior authorization (PA) requirement, combined with the need to get patients on therapy quickly, leads to drugs being dispensed before insurance coverage is assured. Millions of dollars are lost as a consequence. CoverMyMeds' automated service makes PA management faster and less wasteful, and better protects at-risk dollars.
Presented by CoverMyMeds |
